Cubist Systematic Strategies’s Dyne Therapeutics DYN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.65M | Buy |
278,362
+162,828
| +141% | +$1.55M | 0.01% | 657 |
|
|
2025
Q1 | $1.21M | Sell |
115,534
-3,531
| -3% | -$36.9K | 0.01% | 830 |
|
|
2024
Q4 | $2.81M | Buy |
+119,065
| New | +$2.81M | 0.02% | 507 |
|
|
2024
Q2 | – | Sell |
-42,817
| Closed | -$1.22M | – | 1760 |
|
|
2024
Q1 | $1.22M | Buy |
+42,817
| New | +$1.22M | 0.01% | 1061 |
|
|
2023
Q2 | – | Sell |
-27,240
| Closed | -$314K | – | 2460 |
|
|
2023
Q1 | $314K | Sell |
27,240
-2,152
| -7% | -$24.8K | ﹤0.01% | 2016 |
|
|
2022
Q4 | $341K | Buy |
29,392
+2,362
| +9% | +$27.4K | ﹤0.01% | 2387 |
|
|
2022
Q3 | $343K | Buy |
27,030
+26,874
| +17,227% | +$341K | ﹤0.01% | 2717 |
|
|
2022
Q2 | $1K | Sell |
156
-1,157
| -88% | -$7.42K | ﹤0.01% | 3785 |
|
|
2022
Q1 | $13K | Sell |
1,313
-11,969
| -90% | -$119K | ﹤0.01% | 3462 |
|
|
2021
Q4 | $158K | Buy |
13,282
+4,904
| +59% | +$58.3K | ﹤0.01% | 3099 |
|
|
2021
Q3 | $136K | Buy |
8,378
+7,466
| +819% | +$121K | ﹤0.01% | 2680 |
|
|
2021
Q2 | $19K | Buy |
+912
| New | +$19K | ﹤0.01% | 2850 |
|
|
2021
Q1 | – | Sell |
-10,031
| Closed | -$211K | – | 2860 |
|
|
2020
Q4 | $211K | Buy |
+10,031
| New | +$211K | ﹤0.01% | 2214 |
|